JERMUTUS; LUTZ
Patent Applications and Registrations
Patent applications and USPTO patent grants for JERMUTUS; LUTZ.The latest application filed is for "cyclodextrin based injectable coformulations of sglt2 inhibitors and incretin peptides".
- JERMUTUS; LUTZ - CAMBRIDGE GB
- Jermutus; Lutz - Buckhunt Hill GB
- Jermutus, Lutz - US
- Jermutus; Lutz - Gummersbach DE
| Patent | Date |
|---|---|
| Cyclodextrin Based Injectable Coformulations Of Sglt2 Inhibitors And Incretin Peptides App 20220249617 - LAINE; ANNE-LAURE ; et al. | 2022-08-11 |
| Conjugates For Targeting And Clearing Aggregates App 20220001016 - Crowther; Damian C. ; et al. | 2022-01-06 |
| Conjugates for targeting and clearing aggregates Grant 11,065,336 - Crowther , et al. July 20, 2 | 2021-07-20 |
| Glucagon And Glp-1 Co-agonists For The Treatment Of Chronic Kidney Disease And Diabetic Kidney Disease In Type 2 Diabetes App 20210213104 - PARKER; VICTORIA ; et al. | 2021-07-15 |
| Binding Molecules Specific For Cd73 And Uses Thereof App 20200079877 - HAY; Carl ; et al. | 2020-03-12 |
| Binding molecules specific for CD73 and uses thereof Grant 10,556,968 - Hay , et al. Feb | 2020-02-11 |
| Conjugates For Targeting And Clearing Aggregates App 20190328889 - Crowther; Damian C. ; et al. | 2019-10-31 |
| Binding Molecules Specific For Cd73 And Uses Thereof App 20190292274 - HAY; Carl ; et al. | 2019-09-26 |
| Binding molecules specific for CD73 and uses thereof Grant 10,287,362 - Hay , et al. | 2019-05-14 |
| Human Antibody Molecules For Il-13 App 20180230209 - MONK; Phillip David ; et al. | 2018-08-16 |
| Binding Molecules Specific For Cd73 And Uses Thereof App 20180194858 - HAY; Carl ; et al. | 2018-07-12 |
| Binding molecules specific for CD73 and uses thereof Grant 9,938,356 - Hay , et al. April 10, 2 | 2018-04-10 |
| Human antibody molecules for IL-13 Grant 9,856,317 - Monk , et al. January 2, 2 | 2018-01-02 |
| Human Antibody Molecules For Il-13 App 20160280779 - MONK; Phillip David ; et al. | 2016-09-29 |
| Binding Molecules Specific For Cd73 And Uses Thereof App 20160194407 - HAY; Carl ; et al. | 2016-07-07 |
| Methods of treatment using human antibody molecules for IL-13 Grant 9,315,575 - Monk , et al. April 19, 2 | 2016-04-19 |
| Methods and means relating to protein variants Grant 8,288,123 - Buchanan , et al. October 16, 2 | 2012-10-16 |
| Protease Variants App 20120237496 - Birkenfeld; Joerg ; et al. | 2012-09-20 |
| Human Antibody Molecules For IL-13 App 20120052060 - Monk; Phillip David ; et al. | 2012-03-01 |
| Human antibody molecules for IL-13 Grant 7,947,273 - Monk , et al. May 24, 2 | 2011-05-24 |
| Human antibody molecules for IL-13 Grant 7,829,090 - Monk , et al. November 9, 2 | 2010-11-09 |
| Human antibody molecules for IL-13 App 20090123478 - Monk; Phillip David ; et al. | 2009-05-14 |
| Erythropoietin Protein Variants App 20080194475 - Buchanan; Andrew ; et al. | 2008-08-14 |
| Ribosome Display or Mrna Display Method With Selection for Increased Stability of the Protein App 20070298430 - Buchanan; Andrew ; et al. | 2007-12-27 |
| Human antibody molecules for il-13 App 20070128192 - Monk; Philip David ; et al. | 2007-06-07 |
| Methods and means relating to protein variants App 20060183200 - Buchanan; Andrew ; et al. | 2006-08-17 |
| Human antibody molecules for IL-13 App 20050065327 - Monk, Phillip David ; et al. | 2005-03-24 |
| Polysome display in the absence of functional ssrA-RNA Grant 6,589,741 - Pluckthun , et al. July 8, 2 | 2003-07-08 |
| Novel methods for identifying nucleic acid molecules encoding (poly) peptides that interact with target molecules App 20020115083 - Pluckthun, Andreas ; et al. | 2002-08-22 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 